Rockland Technimed Ltd
has
introduced a new line of breakthrough paradigm shifting and natural
Metabolic Magnetic Resonance Imaging products, namely Oxy-17®.They
are used in
conjunction with an unaltered MRI scanner (independent of field
strength); thereby essentially
converting MRI into a Clinical Metabolic Molecular and
Physiologic
real time Imager for use in drug
development, pre-clinical and clinical use.
A result of over 18 years
of research and development effort, during this period of time it has
demonstrated its usefulness in tracking all facets of inVivo oxygen
metabolism using normally installed MRI scanners. Examples are:
Ability to assess tissue
viability in cases of neurological and cardiovascular catastrophes
such as ( Heart or Stroke attack), or other tissue injury such as
Oncology -Cancer.
Ability to determine Oxygen
Extraction Fraction [OEF] of Tissue such as in stroke at a 1 mm
resolution , because they can cross the intact blood brain
barrier. [presently can only be done with PET/CT, using a
radio-active isotope oxygen-15] at its best resolution of 6 mm.
Current PET studies show,
with OEF as an indicator the “Golden hour - 3 Hours after onset
of Stroke” can now be extended up to 12 hours or more, enabling
the clinician and thereby saving lives, reducing disabilities and
costs.
Ability to track tumor
angiogenesis
Oxy-17® and OxyMaps™ are
useful as " Non Invasive Realtime Tissue Stress Monitor"
to evaluate normal and abnormal Oxygen Consumption rates in a
biological subject, without any limitations on repeating the test
due to dosage and/or other limitations.
The Product Oxy-17® are oxygen metabolic imaging
bioscale (TVI-agents) which are injected intravenously prior to Imaging in a standard MRI scanner.
Read More>>
The Proof Images of cardiac ischemic injury showing identification of tissue at risk (dying ) but viable (at the reversible stage), enabling early clinical intervention. Notice that Oxy-17® TVI results in negative contrast. Read More>>
Oxy-17®
is registered as a Trade Mark of Rockland Technimed Ltd for:
Oxygen-based diagnostic agents, preparations and substances for medical
purposes, namely, contrast media for medical imaging for use with MRI
diagnostic apparatus, and diagnostic scanning agents in the nature of
contrast media for use in In-Vivo imaging. Reg # 3,421,019
What the press says :
Brain Energy Metabolism & Blood Flow
August 12-17, 2012
Colby College
Waterville, ME
We
invite you to visit us at our Exhibit Booth # 335
Oxy-17®
is registered as a Trade Mark of Rockland Technimed Ltd for:
Oxygen-based diagnostic agents, preparations and substances for medical
purposes, namely, contrast media for medical imaging for use with MRI
diagnostic apparatus, and diagnostic scanning agents in the nature of
contrast media for use in In-Vivo imaging. Reg # 3,421,019